- Home
- SLNO vs NEO Comparison
SLNO vs NEO Comparison
Compare SLNO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- NEO
- Stock Information
- Founded
- SLNO 1999
- NEO 2001
- Country
- SLNO United States
- NEO United States
- Employees
- SLNO N/A
- NEO N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NEO Precision Instruments
- Sector
- SLNO Health Care
- NEO Health Care
- Exchange
- SLNO Nasdaq
- NEO Nasdaq
- Market Cap
- SLNO 1.9B
- NEO 2.1B
- IPO Year
- SLNO 2014
- NEO 1999
- Fundamental
- Price
- SLNO $53.89
- NEO $13.22
- Analyst Decision
- SLNO Strong Buy
- NEO Strong Buy
- Analyst Count
- SLNO 7
- NEO 9
- Target Price
- SLNO $68.71
- NEO $19.89
- AVG Volume (30 Days)
- SLNO 803.1K
- NEO 869.0K
- Earning Date
- SLNO 11-05-2024
- NEO 11-05-2024
- Dividend Yield
- SLNO N/A
- NEO N/A
- EPS Growth
- SLNO N/A
- NEO N/A
- EPS
- SLNO N/A
- NEO N/A
- Revenue
- SLNO N/A
- NEO $628,248,000.00
- Revenue This Year
- SLNO N/A
- NEO $12.95
- Revenue Next Year
- SLNO N/A
- NEO $9.49
- P/E Ratio
- SLNO N/A
- NEO N/A
- Revenue Growth
- SLNO N/A
- NEO 13.89
- 52 Week Low
- SLNO $21.30
- NEO $12.77
- 52 Week High
- SLNO $56.81
- NEO $21.22
- Technical
- Relative Strength Index (RSI)
- SLNO 57.97
- NEO 36.35
- Support Level
- SLNO $53.02
- NEO $12.77
- Resistance Level
- SLNO $54.86
- NEO $14.19
- Average True Range (ATR)
- SLNO 2.13
- NEO 0.49
- MACD
- SLNO 0.23
- NEO 0.00
- Stochastic Oscillator
- SLNO 68.82
- NEO 27.11
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.